Log In
Print
BCIQ
Print
Print this Print this
 

Amitifadine (formerly DOV 21,947, EB-1010)

  Manage Alerts
Collapse Summary General Information
Company Euthymics Bioscience Inc.
DescriptionSerotonin, norepinephrine and dopamine reuptake inhibitor (SNDRI) that preferentially targets serotonin
Molecular Target Monoamine transporters
Mechanism of ActionMonoamine reuptake inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase II/III
Standard IndicationDepression
Indication DetailsTreat depression; Treat major depressive disorder (MDD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today